These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Design, synthesis, and pharmacological evaluation of N-bicyclo-5-chloro-1H-indole-2-carboxamide derivatives as potent glycogen phosphorylase inhibitors. Onda K; Shiraki R; Ogiyama T; Yokoyama K; Momose K; Katayama N; Orita M; Yamaguchi T; Furutani M; Hamada N; Takeuchi M; Okada M; Ohta M; Tsukamoto S Bioorg Med Chem; 2008 Dec; 16(23):10001-12. PubMed ID: 18952447 [TBL] [Abstract][Full Text] [Related]
64. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes. Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587 [TBL] [Abstract][Full Text] [Related]
65. Discovery of a series of phosphonic acid-containing thiazoles and orally bioavailable diamide prodrugs that lower glucose in diabetic animals through inhibition of fructose-1,6-bisphosphatase. Dang Q; Liu Y; Cashion DK; Kasibhatla SR; Jiang T; Taplin F; Jacintho JD; Li H; Sun Z; Fan Y; DaRe J; Tian F; Li W; Gibson T; Lemus R; van Poelje PD; Potter SC; Erion MD J Med Chem; 2011 Jan; 54(1):153-65. PubMed ID: 21126019 [TBL] [Abstract][Full Text] [Related]
66. Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes. Xu Q; Huang L; Liu J; Ma L; Chen T; Chen J; Peng F; Cao D; Yang Z; Qiu N; Qiu J; Wang G; Liang X; Peng A; Xiang M; Wei Y; Chen L Eur J Med Chem; 2012 Jun; 52():70-81. PubMed ID: 22483089 [TBL] [Abstract][Full Text] [Related]
67. (WO2011057959) indole and indazole derivatives as glycogen synthase activators: a patent evaluation. Skaltsounis AL; Gaboriaud-Kolar N Expert Opin Ther Pat; 2011 Dec; 21(12):1925-9. PubMed ID: 21988345 [TBL] [Abstract][Full Text] [Related]